BORN TO DISCOVER

25+ YEAR HISTORY

We are the only biopharmaceutical company led by physician-scientists for our entire, nearly 30-year history. From our first days, science was and remains our central guiding principle. We continue to invest in groundbreaking technologies and research, and employ strategies that enable our scientists to consistently explore new paths.

Read a profile of Regeneron Scientist Aynur Hermann
Read a profile of Regeneron Scientist Xiaobin Xu

REGENERON LABS

We are focused on addressing a broad range of serious medical conditions including ophthalmology, cancer, rheumatoid arthritis, asthma, atopic dermatitis, pain and infectious diseases. Our industry-leading research and development engine enables us to develop all potential drug candidates from within our own labs.

Our science

DIVERSE PIPELINE

Our strategy is to follow the science, rather than limiting our innovations to any one therapeutic area. We are focused on solving the human body's most complex mysteries — from ophthalmology to cancer to inflammation to pain to cardiovascular disease. This includes twelve antibodies currently in clinical trials.

Our pipeline

TECHNOLOGY THAT BREAKS BOTTLENECKS

Our core capabilities for target discovery and validation are enabled by a series of Regeneron-invented technologies that accelerate, improve and disrupt the traditional drug discovery and development process. Collectively, these technologies represent some of the most valuable biotechnologies ever created, and aid our efforts to continuously accelerate the average timeline from discovery to drug approval.

See how we're raising the bar

REGENERON
GENETICS CENTER

We have built one of the world's most comprehensive genotype-phenotype databases, enabling deeper understanding of the genetic factors that cause or influence a range of human diseases.

The Regeneron Genetics Center

PUBLICATIONS

We encourage our pioneering scientists to regularly publish their research in leading scientific journals, including 68 in 2015 alone.

Recent publications

INNOVATIVE LEADERSHIP

We consistently demonstrate our commitment to scientific excellence by including multiple Nobel Laureates and five members of the National Academy of Sciences in our leadership, as well as being one of the first companies to form a Science and Technology Committee as an integral component of its Board, a practice which has since become industry standard. We are also the proud sponsors of the Regeneron Science Talent Search.

Our leadership

UNITED IN DISCOVERY

Along with our distinguished collaborators, we are uncovering cutting-edge scientific advances. Partner with our researchers and help turn science into life-changing medicine.

Our collaborations

NOW APPROVED IN THE UNITED STATES

Learn more